Association Between Acid-Suppressive Agents’ Use and Risk of Hepatocellular Carcinoma

BACKGROUND: Acid-suppressive agents (ASAs), which are mostly used in patients with upper gastrointestinal diseases (UGIDs), may influence the risk of hepatocellular carcinoma (HCC). METHODS: A population-based retrospective cohort study was conducted. Patients with UGID who used ASAs and those who d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hsiu C., Hsu, Huan Y., Lin, Hsiu L., Uang, Yow S., Ho, Yi, Wang, Li H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851131/
https://www.ncbi.nlm.nih.gov/pubmed/35185412
http://dx.doi.org/10.1177/1559325820907530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851131/
https://www.ncbi.nlm.nih.gov/pubmed/35185412
http://dx.doi.org/10.1177/1559325820907530

Ejemplares similares